These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Contrast-enhanced MR imaging of the female pelvis. Hricak H; Kim B J Magn Reson Imaging; 1993; 3(1):297-306. PubMed ID: 8428097 [No Abstract] [Full Text] [Related]
10. Considerations in the choice of contrast media for MR imaging. Brasch RC; Bennett HF Radiology; 1988 Mar; 166(3):897-9. PubMed ID: 3340795 [No Abstract] [Full Text] [Related]
11. Magnetization transfer contrast in Gd-DTPA-enhanced imaging of brain tumors. Niemi P; Kurki T; Lundbom N; Kormano M Invest Radiol; 1991 Nov; 26 Suppl 1():S248-9; discussion S253-4. PubMed ID: 1808140 [No Abstract] [Full Text] [Related]
12. Gd-DTPA as a contrast agent in CT. Bloem JL; Wondergem J Radiology; 1989 May; 171(2):578-9. PubMed ID: 2704827 [TBL] [Abstract][Full Text] [Related]
13. Gadolinium-DTPA-enhanced magnetic resonance imaging in intractable partial epilepsy. Cascino GD; Hirschorn KA; Jack CR; Sharbrough FW Neurology; 1989 Aug; 39(8):1115-8. PubMed ID: 2503770 [TBL] [Abstract][Full Text] [Related]
14. Magnetic resonance imaging of brain perfusion using the nonionic contrast agents Dy-DTPA-BMA and Gd-DTPA-BMA. Kucharczyk J; Asgari H; Mintorovitch J; Vexler Z; Moseley M; Watson A; Rocklage S Invest Radiol; 1991 Nov; 26 Suppl 1():S250-2; discussion S253-4. PubMed ID: 1808141 [No Abstract] [Full Text] [Related]
15. Magnetic resonance imaging contrast enhancement versus tissue gadolinium concentration. Wang SC; White DL; Pope JM; Brasch RC Invest Radiol; 1990 Sep; 25 Suppl 1():S44-5. PubMed ID: 2283253 [No Abstract] [Full Text] [Related]
16. Is it necessary to routinely use gadolinium in the MR imaging evaluation of soft-tissue tumors of the extremities? Kransdorf MJ AJR Am J Roentgenol; 1995 Dec; 165(6):1545. PubMed ID: 7484606 [No Abstract] [Full Text] [Related]